These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30018707)

  • 1. Exosome-related lncRNAs as predictors of HCC patient survival: a prognostic model.
    Hou Y; Yu Z; Tam NL; Huang S; Sun C; Wang R; Zhang X; Wang Z; Ma Y; He X; Wu L
    Am J Transl Res; 2018; 10(6):1648-1662. PubMed ID: 30018707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
    Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
    Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
    Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
    Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma.
    Li C; Zhang W; Yang H; Xiang J; Wang X; Wang J
    PeerJ; 2020; 8():e8758. PubMed ID: 32201648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of ceRNA network reveals potential prognostic Hint1-related lncRNAs involved in hepatocellular carcinoma progression.
    Zhang C; Bao T; Ke Y; Liu X; Wang X; Liao W; He Y; Wang L
    World J Surg Oncol; 2022 Mar; 20(1):67. PubMed ID: 35241097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.
    Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y
    Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
    Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
    Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Wang J; Pu J; Yao T; Lu X; Deng Y
    J Cell Physiol; 2019 Jun; 234(6):8709-8716. PubMed ID: 30417366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomewide identification of a novel six-LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma.
    Wu Y; Wang PS; Wang BG; Xu L; Fang WX; Che XF; Qu XJ; Liu YP; Li Z
    Cancer Med; 2018 Dec; 7(12):6219-6233. PubMed ID: 30378276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
    J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis.
    Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ
    Front Oncol; 2022; 12():1022097. PubMed ID: 36300102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma.
    Sun JR; Kong CF; Xiao KM; Yang JL; Qu XK; Sun JH
    Front Genet; 2020; 11():602542. PubMed ID: 33381151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
    Jiang W; Guo Q; Wang C; Zhu Y
    Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy.
    Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY
    J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive
    Wang Z; Ji X; Gao L; Guo X; Lian W; Deng K; Xing B
    Front Oncol; 2021; 11():553594. PubMed ID: 33747903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of CTD-2547G23.4 in hepatocellular carcinoma tissues and its prospective molecular regulatory mechanism: a novel qRT-PCR and bioinformatics analysis study.
    Wen DY; Lin P; Liang HW; Yang X; Li HY; He Y; Yang H; Chen G
    Cancer Cell Int; 2018; 18():74. PubMed ID: 29780284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.